SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 95 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,419,000 | -19.1% | 2,512,705 | 0.0% | 0.77% | +26.1% |
| Q1 2022 | $2,990,000 | -63.5% | 2,512,705 | 0.0% | 0.61% | -47.2% |
| Q4 2021 | $8,191,000 | -27.1% | 2,512,705 | 0.0% | 1.16% | -8.1% |
| Q3 2021 | $11,232,000 | -9.4% | 2,512,705 | +10.5% | 1.26% | -10.2% |
| Q2 2021 | $12,398,000 | +6.1% | 2,274,831 | +45.6% | 1.40% | +26.9% |
| Q1 2021 | $11,688,000 | -31.1% | 1,562,500 | 0.0% | 1.11% | -56.5% |
| Q4 2020 | $16,953,000 | – | 1,562,500 | – | 2.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |